Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

Novartis settles Sun Pharma suit, winning 7-month reprieve from generic Gleevec

15.05.2014 / Fierce Pharma

After nearly a year of fighting to protect the patent on its blockbuster leukemia drug Gleevec, Novartis has made peace with Indian drugmaker Sun Pharma, reaching a settlement that will keep Sun&#39;s generic version off the U.S. market until February 2016, <em>Reuters</em> reports. Novartis&#39; U.S. patent expires in July 2015.

Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: